Difficulty: Medium
Average Score: 88%
Practice
Hepatitis C virus infection is a risk factor for which of the following malignancy?
Correct answer
B
Rationale
The correct answer is B) splenic lymphoma. Hepatitis C virus infection is associated with an increased risk of developing non-Hodgkin lymphoma, particularly splenic lymphoma. This is due to the chronic inflammatory state caused by the virus, which can lead to the development of lymphoproliferative disorders.
Option A) hepatoblastoma is a rare liver cancer that primarily affects children and is not directly linked to hepatitis C virus infection.
Option C) Hodgkin lymphoma is a different type of lymphoma compared to non-Hodgkin lymphoma, which is the one associated with hepatitis C virus infection.
Option D) nasopharyngeal carcinoma is not directly linked to hepatitis C virus infection. It is more commonly associated with other factors such as Epstein-Barr virus infection and environmental factors.
In an educational context, understanding the relationship between viral infections like hepatitis C and their potential impact on malignancy is crucial for healthcare providers, especially in pediatrics. This knowledge can guide appropriate screening, management, and treatment strategies for patients with hepatitis C infection to prevent or detect associated malignancies early.
Option A) hepatoblastoma is a rare liver cancer that primarily affects children and is not directly linked to hepatitis C virus infection.
Option C) Hodgkin lymphoma is a different type of lymphoma compared to non-Hodgkin lymphoma, which is the one associated with hepatitis C virus infection.
Option D) nasopharyngeal carcinoma is not directly linked to hepatitis C virus infection. It is more commonly associated with other factors such as Epstein-Barr virus infection and environmental factors.
In an educational context, understanding the relationship between viral infections like hepatitis C and their potential impact on malignancy is crucial for healthcare providers, especially in pediatrics. This knowledge can guide appropriate screening, management, and treatment strategies for patients with hepatitis C infection to prevent or detect associated malignancies early.